ATryn (GTC Biotherapeutics, Inc.)


Welcome to the PulseAid listing for the ATryn drug offered from GTC Biotherapeutics, Inc.. This Recombinant Antithrombin [EPC],Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GTC Biotherapeutics, Inc.
NON-PROPRIETARY NAME: Antithrombin (Recombinant)
SUBSTANCE NAME: ANTITHROMBIN ALFA
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Recombinant Antithrombin [EPC],Decreased Coagulation Factor Activity [PE],Thrombin Inhibitors [MoA],Factor Xa Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2009-05-06
END MARKETING DATE: 0000-00-00


ATryn HUMAN PRESCRIPTION DRUG Details:

Item DescriptionATryn from GTC Biotherapeutics, Inc.
LABELER NAME: GTC Biotherapeutics, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1750([iU]/1)
START MARKETING DATE: 2009-05-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42976-121_ed3eaf69-1cbd-4b01-a6fa-1fe02c90c3e1
PRODUCT NDC: 42976-121
APPLICATION NUMBER: BLA125284

Other ANTITHROMBIN ALFA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GTC Biotherapeutics, Inc.ATryn
rEVO Bioloigics, Inc.ATryn